Price
$0.41
Decreased by -20.92%
Dollar volume (20D)
4.19 M
ADR%
24.84
Shares float
14.70 M
Shares short
45.73 K [0.31%]
Shares outstanding
24.82 M
Market cap
10.62 M
Beta
N/A
Price/earnings
N/A
20D range
0.21 1.12
50D range
0.15 1.12
200D range
0.14 1.34

Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States.

It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name.

The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com.

Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program.

The company was incorporated in 2021 and is headquartered in Dallas, Texas.

Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Sep 30, 23 -0.11
Decreased by -465.00%
-
Jun 30, 23 -0.14 -
May 10, 23 -0.23 -
Feb 6, 23 -0.06 -
Sep 26, 22 -0.02 -
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 23 245.16 K
Increased by +N/A%
-1.80 M
Decreased by -84.50%
Decreased by -733.99%
Decreased by N/A%
Jun 30, 23 141.24 K
Increased by +N/A%
-2.28 M
Decreased by -593.21%
Decreased by -1.62 K%
Decreased by N/A%
Mar 31, 23 100.72 K
Increased by +N/A%
-2.56 M
Decreased by -12.97 K%
Decreased by -2.54 K%
Decreased by N/A%
Dec 31, 22 8.94 K
Increased by +N/A%
-673.65 K
Decreased by -3.71 K%
Decreased by -7.54 K%
Decreased by N/A%
Sep 30, 22 0.00 - -975.32 K -
Decreased by N/A%
-
Jun 30, 22 0.00 - -329.49 K -
Decreased by N/A%
-
Mar 31, 22 0.00 - -19.60 K -
Decreased by N/A%
-
Dec 31, 21 0.00 - -17.70 K -
Decreased by N/A%
-
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY